Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 414

1.

Utilization Patterns of Amantadine in Parkinson's Disease Patients Enrolled in the French COPARK Study.

Rascol O, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Fabbri M, Meissner WG, Rachdi A, Tison F, Perez-Lloret S; COPARK Study Group.

Drugs Aging. 2020 Jan 10. doi: 10.1007/s40266-019-00740-2. [Epub ahead of print]

PMID:
31919803
2.

Microarray expression studies on bone marrow of patients with Shwachman-Diamond syndrome in relation to deletion of the long arm of chromosome 20, other chromosome anomalies or normal karyotype.

Khan AW, Minelli A, Frattini A, Montalbano G, Bogni A, Fabbri M, Porta G, Acquati F, Pinto RM, Bergami E, Mura R, Pegoraro A, Cesaro S, Cipolli M, Zecca M, Danesino C, Locatelli F, Maserati E, Pasquali F, Valli R.

Mol Cytogenet. 2020 Jan 2;13:1. doi: 10.1186/s13039-019-0466-9. eCollection 2020.

3.

In vitro and bioinformatics mechanistic-based approach for cadmium carcinogenicity understanding.

Oldani M, Fabbri M, Melchioretto P, Callegaro G, Fusi P, Gribaldo L, Forcella M, Urani C.

Toxicol In Vitro. 2020 Jan 3;65:104757. doi: 10.1016/j.tiv.2020.104757. [Epub ahead of print]

4.

Regulation of miRNAs as new tool for cutaneous vitality lesions demonstration in ligature marks in deaths by hanging.

Neri M, Fabbri M, D'Errico S, Di Paolo M, Frati P, Gaudio RM, La Russa R, Maiese A, Marti M, Pinchi E, Turillazzi E, Fineschi V.

Sci Rep. 2019 Dec 27;9(1):20011. doi: 10.1038/s41598-019-56682-7.

5.

Correction: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.

Semba S, Trapasso F, Fabbri M, McCorkell KA, Volinia S, Druck T, Iliopoulos D, Pekarsky Y, Ishii H, Garrison PN, Barnes LD, Croce CM, Huebner K.

Oncogene. 2019 Dec 9. doi: 10.1038/s41388-019-1130-x. [Epub ahead of print]

PMID:
31819168
6.

Levodopa response in later stages of Parkinson's disease: A case-control study.

Fabbri M, Coelho M, Abreu D, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Oct 29. pii: S1353-8020(19)30470-5. doi: 10.1016/j.parkreldis.2019.10.027. [Epub ahead of print] No abstract available.

PMID:
31722819
7.

Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?

Fabbri M.

Cancer Res. 2020 Jan 1;80(1):17-22. doi: 10.1158/0008-5472.CAN-19-1450. Epub 2019 Oct 31. Review.

PMID:
31672842
8.

Population Structure and Genetic Diversity of Italian Beef Breeds as a Tool for Planning Conservation and Selection Strategies.

Fabbri MC, Gonçalves de Rezende MP, Dadousis C, Biffani S, Negrini R, Souza Carneiro PL, Bozzi R.

Animals (Basel). 2019 Oct 29;9(11). pii: E880. doi: 10.3390/ani9110880.

9.

In vitro human cord blood platelet lysate characterisation with potential application in wound healing.

Losi P, Barsotti MC, Foffa I, Buscemi M, De Almeida CV, Fabbri M, Gabbriellini S, Nocchi F, Ursino S, Urciuoli P, Mazzoni A, Soldani G.

Int Wound J. 2020 Feb;17(1):65-72. doi: 10.1111/iwj.13233. Epub 2019 Oct 30.

PMID:
31665826
10.

Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors.

Artusi CA, Balestrino R, Imbalzano G, Bortolani S, Montanaro E, Tuttobene S, Fabbri M, Zibetti M, Lopiano L.

Parkinsonism Relat Disord. 2019 Oct 9. pii: S1353-8020(19)30431-6. doi: 10.1016/j.parkreldis.2019.10.004. [Epub ahead of print]

PMID:
31610986
11.

Workaholism, Intensive Smartphone Use, and the Sleep-Wake Cycle: A Multiple Mediation Analysis.

Spagnoli P, Balducci C, Fabbri M, Molinaro D, Barbato G.

Int J Environ Res Public Health. 2019 Sep 20;16(19). pii: E3517. doi: 10.3390/ijerph16193517.

12.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2019 Dec 1;30(12):2015. doi: 10.1093/annonc/mdz386. No abstract available.

13.

Mitochondrial Ca2+ -activated F1 FO -ATPase hydrolyzes ATP and promotes the permeability transition pore.

Algieri C, Trombetti F, Pagliarani A, Ventrella V, Bernardini C, Fabbri M, Forni M, Nesci S.

Ann N Y Acad Sci. 2019 Dec;1457(1):142-157. doi: 10.1111/nyas.14218. Epub 2019 Aug 23.

PMID:
31441951
14.

Decrypting noncoding RNA interactions, structures, and functional networks.

Fabbri M, Girnita L, Varani G, Calin GA.

Genome Res. 2019 Sep;29(9):1377-1388. doi: 10.1101/gr.247239.118. Epub 2019 Aug 21. Review.

15.

Validation of the Italian version of the PSP Quality of Life questionnaire.

Picillo M, Cuoco S, Amboni M, Bonifacio FP, Bruschi F, Carotenuto I, De Micco R, De Rosa A, Del Prete E, Di Biasio F, Elifani F, Erro R, Fabbri M, Falla M, Franco G, Frosini D, Galantucci S, Lazzeri G, Magistrelli L, Malaguti MC, Milner AV, Minafra B, Olivola E, Pilotto A, Rascunà C, Rizzetti MC, Schirinzi T, Borroni B, Ceravolo R, Di Fonzo A, Marchese R, Mercuri NB, Modugno N, Nicoletti A, Padovani A, Santangelo G, Stefani A, Tessitore A, Volontè MA, Zangaglia R, Zappia M, Zibetti M, Barone P.

Neurol Sci. 2019 Dec;40(12):2587-2594. doi: 10.1007/s10072-019-04010-2. Epub 2019 Jul 26.

PMID:
31350659
16.

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri EM, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P.

Int J Cancer. 2020 Apr 1;146(7):1917-1929. doi: 10.1002/ijc.32583. Epub 2019 Aug 7.

PMID:
31330065
17.

miR-1, miR-499 and miR-208 are sensitive markers to diagnose sudden death due to early acute myocardial infarction.

Pinchi E, Frati P, Aromatario M, Cipolloni L, Fabbri M, La Russa R, Maiese A, Neri M, Santurro A, Scopetti M, Viola RV, Turillazzi E, Fineschi V.

J Cell Mol Med. 2019 Sep;23(9):6005-6016. doi: 10.1111/jcmm.14463. Epub 2019 Jun 26.

18.

Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy.

Picillo M, Cuoco S, Amboni M, Bonifacio FP, Bruno A, Bruschi F, Cappiello A, De Micco R, De Rosa A, Di Biasio F, Elifani F, Erro R, Fabbri M, Falla M, Franco G, Frosini D, Galantucci S, Lazzeri G, Magistrelli L, Malaguti MC, Milner AV, Minafra B, Olivola E, Pilotto A, Rascunà C, Rizzetti MC, Schirinzi T, Borroni B, Ceravolo R, Di Fonzo A, Lopiano L, Marchese R, Mercuri NB, Modugno N, Nicoletti A, Padovani A, Santangelo G, Stefani A, Tessitore A, Volontè MA, Zangaglia R, Zappia M, Barone P.

Neurol Sci. 2019 Oct;40(10):2163-2169. doi: 10.1007/s10072-019-03944-x. Epub 2019 Jun 12.

PMID:
31190253
19.

Corrigendum to "MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis" Clinical Biochemistry 46 (2013) 918-925.

Vannini I, Fanini F, Fabbri M.

Clin Biochem. 2019 Jun;68:58. doi: 10.1016/j.clinbiochem.2019.05.004. Epub 2019 May 23. No abstract available.

PMID:
31128843
20.

Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?

Fabbri M, Zibetti M, Ferrero G, Accornero A, Guimaraes I, Rizzone MG, Romagnolo A, Ferreira JJ, Lopiano L.

Parkinsonism Relat Disord. 2019 Jul;64:242-248. doi: 10.1016/j.parkreldis.2019.04.018. Epub 2019 Apr 28.

PMID:
31060986
21.

Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson's disease.

Fabbri M, Pongmala C, Artusi CA, Romagnolo A, Rizzone MG, Zibetti M, Lopiano L.

Acta Neurol Scand. 2019 Aug;140(2):157-161. doi: 10.1111/ane.13110. Epub 2019 May 13.

PMID:
31025312
22.

Dysphagia predicts poor outcome in late-stage Parkinson's disease.

Fabbri M, Coelho M, Abreu D, Guedes LC, Rosa MM, Godinho C, Cardoso R, Guimaraes I, Antonini A, Zibetti M, Lopiano L, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Jul;64:73-81. doi: 10.1016/j.parkreldis.2019.02.043. Epub 2019 Mar 2.

PMID:
30902528
23.

Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells.

Wu CH, Li J, Li L, Sun J, Fabbri M, Wayne AS, Seeger RC, Jong AY.

J Extracell Vesicles. 2019 Mar 12;8(1):1588538. doi: 10.1080/20013078.2019.1588538. eCollection 2019.

24.

Type 1 Diabetes in STAT Protein Family Mutations: Regulating the Th17/Treg Equilibrium and Beyond.

Fabbri M, Frixou M, Degano M, Fousteri G.

Diabetes. 2019 Feb;68(2):258-265. doi: 10.2337/db18-0627.

25.

Dissecting diffuse large B-cell lymphomas of the "not otherwise specified" type: the impact of molecular techniques.

Pileri SA, Derenzini E, Melle F, Motta G, Calleri A, Antoniotti P, Maltoni V, Spagnolo S, Fiori S, Tabanelli V, Fabbri M.

F1000Res. 2018 Dec 21;7. pii: F1000 Faculty Rev-1966. doi: 10.12688/f1000research.16755.1. eCollection 2018. Review.

26.

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.

Gagno S, D'Andrea MR, Mansutti M, Zanusso C, Puglisi F, Dreussi E, Montico M, Biason P, Cecchin E, Iacono D, Russo S, Cinausero M, Saracchini S, Gasparini G, Sartori D, Bari M, Collovà E, Meo R, Merkabaoui G, Spagnoletti I, Pellegrino A, Gianni L, Sandri P, Cretella E, Vattemi E, Rocca A, Serra P, Fabbri MA, Benedetti G, Foghini L, Medici M, Basso U, Amoroso V, Riccardi F, Baldelli AM, Clerico M, Bonura S, Saggia C, Innocenti F, Toffoli G.

Clin Breast Cancer. 2019 Apr;19(2):137-145.e4. doi: 10.1016/j.clbc.2018.11.009. Epub 2018 Nov 24.

27.

Corrigendum to "MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis" [Clinical Biochemistry 46 (2013) 918-925].

Vannini I, Fanini F, Fabbri M.

Clin Biochem. 2019 Jan;63:162. doi: 10.1016/j.clinbiochem.2018.11.014. Epub 2018 Dec 14. No abstract available.

PMID:
30559003
28.

Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.

Neviani P, Wise PM, Murtadha M, Liu CW, Wu CH, Jong AY, Seeger RC, Fabbri M.

Cancer Res. 2019 Mar 15;79(6):1151-1164. doi: 10.1158/0008-5472.CAN-18-0779. Epub 2018 Dec 12.

PMID:
30541743
29.

Face-from-Depth for Head Pose Estimation on Depth Images.

Borghi G, Fabbri M, Vezzani R, Calderara S, Cucchiara R.

IEEE Trans Pattern Anal Mach Intell. 2020 Mar;42(3):596-609. doi: 10.1109/TPAMI.2018.2885472. Epub 2018 Dec 7.

PMID:
30530311
30.

Fossilization transforms vertebrate hard tissue proteins into N-heterocyclic polymers.

Wiemann J, Fabbri M, Yang TR, Stein K, Sander PM, Norell MA, Briggs DEG.

Nat Commun. 2018 Nov 9;9(1):4741. doi: 10.1038/s41467-018-07013-3.

31.

Anterior cruciate ligament reconstruction is associated with greater tibial tunnel widening when using a bioabsorbable screw compared to an all-inside technique with suspensory fixation.

Monaco E, Fabbri M, Redler A, Gaj E, De Carli A, Argento G, Saithna A, Ferretti A.

Knee Surg Sports Traumatol Arthrosc. 2019 Aug;27(8):2577-2584. doi: 10.1007/s00167-018-5275-x. Epub 2018 Nov 7.

PMID:
30406408
32.

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.

Gamucci T, Pizzuti L, Natoli C, Mentuccia L, Sperduti I, Barba M, Sergi D, Iezzi L, Maugeri-Saccà M, Vaccaro A, Magnolfi E, Gelibter A, Barchiesi G, Magri V, D'Onofrio L, Cassano A, Rossi E, Botticelli A, Moscetti L, Omarini C, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Mazzotta M, Bria E, Foglietta J, Samaritani R, Garufi C, Mariani L, Barni S, Mirabelli R, Sarmiento R, Graziano V, Santini D, Marchetti P, Tonini G, Di Lauro L, Sanguineti G, Paoletti G, Tomao S, De Maria R, Veltri E, Paris I, Giotta F, Latorre A, Giordano A, Ciliberto G, Vici P.

Cancer Biol Ther. 2019;20(2):192-200. doi: 10.1080/15384047.2018.1523095. Epub 2018 Nov 7.

33.

Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.

Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L.

Eur J Neurol. 2019 Mar;26(3):490-496. doi: 10.1111/ene.13844. Epub 2018 Nov 18.

34.

Isokinetic flexion strength recovery after ACL reconstruction: a comparison between all inside graft-link technique and full tibial tunnel technique.

Monaco E, Redler A, Fabbri M, Proietti L, Gaj E, Daggett M, Ferretti A.

Phys Sportsmed. 2019 Feb;47(1):132-135. doi: 10.1080/00913847.2018.1537535. Epub 2018 Nov 2.

PMID:
30347173
35.

Adjunctive Therapies in Parkinson's Disease: How to Choose the Best Treatment Strategy Approach.

Fabbri M, Rosa MM, Ferreira JJ.

Drugs Aging. 2018 Dec;35(12):1041-1054. doi: 10.1007/s40266-018-0599-2. Review.

PMID:
30318555
36.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2018 Dec 1;29(12):2363-2370. doi: 10.1093/annonc/mdy450. Erratum in: Ann Oncol. 2019 Dec 1;30(12):2015. Ann Oncol. 2019 Dec;30(12):2015.

37.

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.

Fabbri M, Ferreira JJ, Lees A, Stocchi F, Poewe W, Tolosa E, Rascol O.

Mov Disord. 2018 Oct;33(10):1528-1539. doi: 10.1002/mds.27475. Epub 2018 Sep 27. Review.

PMID:
30264443
38.

Theory of mind and joint action in Parkinson's disease.

Fabbri M, Vitale C, Cuoco S, Beracci A, Calabrese R, Cordella M, Mazzotta R, Barone P, Pellecchia MT, Santangelo G.

Cogn Affect Behav Neurosci. 2018 Dec;18(6):1320-1337. doi: 10.3758/s13415-018-0642-0.

PMID:
30259349
39.

The human RNASET2 protein affects the polarization pattern of human macrophages in vitro.

Scaldaferri D, Bosi A, Fabbri M, Pedrini E, Inforzato A, Valli R, Frattini A, De Vito A, Noonan DM, Taramelli R, Mortara L, Acquati F.

Immunol Lett. 2018 Nov;203:102-111. doi: 10.1016/j.imlet.2018.09.005. Epub 2018 Sep 12.

PMID:
30218741
40.

Lipid-protein interactions in mitochondrial membranes from bivalve mollusks: molecular strategies in different species.

Fiorini R, Ventrella V, Trombetti F, Fabbri M, Pagliarani A, Nesci S.

Comp Biochem Physiol B Biochem Mol Biol. 2019 Jan;227:12-20. doi: 10.1016/j.cbpb.2018.08.010. Epub 2018 Sep 7.

PMID:
30196154
41.

Epigenetics of gastrointestinal diseases: notes from a workshop.

Marks DL, Olson RL, Urrutia R, Billadeau DD, Roy N, Calin GA, Fabbri M, Koutsioumpa M, Iliopoulos D, Ordog T, Huebert R, Sarmento O, Bamidele AO, Faubion W, Lomberk GL, Siveke J, Ahuja N, Iovanna J, Hlady RA, Robertson K, Kisiel J, Pin CL, Fernandez-Zapico ME.

Epigenetics. 2018;13(4):449-457. doi: 10.1080/15592294.2018.1464351. Epub 2018 Jul 30.

42.

Lifestyle factors and risk for colorectal polyps and cancer at index colonoscopy in a FIT-positive screening population.

Colussi D, Fabbri M, Zagari RM, Montale A, Bazzoli F, Ricciardiello L.

United European Gastroenterol J. 2018 Jul;6(6):935-942. doi: 10.1177/2050640618764711. Epub 2018 Mar 8.

43.

Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis.

Zanotti S, Gibertini S, Blasevich F, Bragato C, Ruggieri A, Saredi S, Fabbri M, Bernasconi P, Maggi L, Mantegazza R, Mora M.

Matrix Biol. 2018 Dec;74:77-100. doi: 10.1016/j.matbio.2018.07.003. Epub 2018 Jul 5.

PMID:
29981373
44.

Beyond 35 years of Parkinson's disease: a comprehensive clinical and instrumental assessment.

Romagnolo A, Fabbri M, Merola A, Montanaro E, Palermo S, Martone T, Seresini A, Goldwurm S, Rizzone MG, Lopiano L.

J Neurol. 2018 Sep;265(9):1989-1997. doi: 10.1007/s00415-018-8955-z. Epub 2018 Jun 26.

PMID:
29943201
45.

Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma.

Derenzini E, Agostinelli C, Rossi A, Rossi M, Scellato F, Melle F, Motta G, Fabbri M, Diop F, Kodipad AA, Chiappella A, Vitolo U, Gaidano G, Tarella C, Pileri S.

Br J Haematol. 2019 Apr;185(2):330-334. doi: 10.1111/bjh.15442. Epub 2018 Jun 17. No abstract available.

46.

Perceived Social Isolation and Outcomes in Patients With Heart Failure.

Manemann SM, Chamberlain AM, Roger VL, Griffin JM, Boyd CM, Cudjoe TKM, Jensen D, Weston SA, Fabbri M, Jiang R, Finney Rutten LJ.

J Am Heart Assoc. 2018 May 23;7(11). pii: e008069. doi: 10.1161/JAHA.117.008069.

47.

Relapsing Malaria: A Case Report of Primaquine Resistance.

Dijanic C, Nickerson J, Shakya S, Dijanic A, Fabbri M.

Case Rep Infect Dis. 2018 Mar 11;2018:9720823. doi: 10.1155/2018/9720823. eCollection 2018.

48.

European Society of Cardiology-Proposed Diagnostic Echocardiographic Algorithm in Elective Patients with Clinical Suspicion of Infective Endocarditis: Diagnostic Yield and Prognostic Implications in Clinical Practice.

Barbieri A, Mantovani F, Lugli R, Bursi F, Fabbri M, Bartolacelli Y, Manicardi M, Stefanelli G, Mussini C, Boriani G.

J Cardiovasc Echogr. 2018 Jan-Mar;28(1):26-31. doi: 10.4103/jcecho.jcecho_49_17.

49.

WITHDRAWN: Corrigendum to 'Development of an Italian RM Y-STR haplotype database: results of the 2013 GEFI collaborative exercise' [Forensic. Sci. Int. Genet. 15 (2015) 56-63].

Robino C, Ralf A, Pasino S, De Marchi MR, Ballantyne KN, Barbaro A, Bini C, Carnevali E, Casarino L, Di Gaetano C, Fabbri M, Ferri G, Giardina E, Gonzalez A, Matullo G, Nutini AL, Onofri 5th, Piccinini A, Piglionica M, Ponzano E, Previderè C, Resta N, Scarnicci F, Seidita G, Sorçaburu-Cigliero S, Turrina S, Verzeletti A, Kayser M.

Forensic Sci Int Genet. 2018 Apr 5. pii: S1872-4973(18)30195-9. doi: 10.1016/j.fsigen.2018.03.014. [Epub ahead of print] No abstract available.

PMID:
29627344
50.

Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.

Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA.

Genome Res. 2018 Apr;28(4):432-447. doi: 10.1101/gr.225128.117. Epub 2018 Mar 22.

Supplemental Content

Loading ...
Support Center